María Victoria
Mateos Manteca
Profesora Titular de Universidad
Consejo Superior de Investigaciones Científicas
Madrid, EspañaPublications in collaboration with researchers from Consejo Superior de Investigaciones Científicas (9)
2024
-
Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cells
British Journal of Haematology
2023
-
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study
Leukemia and Lymphoma
-
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Nature Communications, Vol. 14, Núm. 1
2021
-
Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data
Leukemia, Vol. 35, Núm. 10, pp. 2924-2935
2020
-
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Blood Cancer Journal, Vol. 10, Núm. 10
2018
-
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 18, Núm. 10, pp. e401-e419
2016
-
Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma
Blood, Vol. 127, Núm. 6, pp. 681-695
2009
-
Flow Cytometry Remission Is the Most Relevant Prognostic Factor for MM Patients Who Undergo ASCT
CLINICAL LYMPHOMA & MYELOMA
-
The Presence of Normal PC at Diagnosis by Flow Cytometry is a Favorable Prognostic Feature in MM
CLINICAL LYMPHOMA & MYELOMA